Your browser doesn't support javascript.
loading
Customizable, biocompatible implants for dorsal nasal augmentation: An in vivo pilot study of eight polylactic acid scaffold designs.
O'Connell, Gillian M; Vernice, Nicholas; Matavosian, Alicia A; Slyker, Leigh; Bender, Ryan J; Dong, Xue; Bonassar, Lawrence J; Shin, James; Spector, Jason A.
Afiliação
  • O'Connell GM; Division of Plastic and Reconstructive Surgery, Laboratory of Bioregenerative Medicine and Surgery, Weill Cornell Medicine, New York, New York, USA.
  • Vernice N; Division of Plastic and Reconstructive Surgery, Laboratory of Bioregenerative Medicine and Surgery, Weill Cornell Medicine, New York, New York, USA.
  • Matavosian AA; Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, New York, USA.
  • Slyker L; Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, New York, USA.
  • Bender RJ; Division of Plastic and Reconstructive Surgery, Laboratory of Bioregenerative Medicine and Surgery, Weill Cornell Medicine, New York, New York, USA.
  • Dong X; Division of Plastic and Reconstructive Surgery, Laboratory of Bioregenerative Medicine and Surgery, Weill Cornell Medicine, New York, New York, USA.
  • Bonassar LJ; Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, New York, USA.
  • Shin J; Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, New York, New York, USA.
  • Spector JA; Division of Plastic and Reconstructive Surgery, Laboratory of Bioregenerative Medicine and Surgery, Weill Cornell Medicine, New York, New York, USA.
J Biomed Mater Res A ; 2024 Jun 14.
Article em En | MEDLINE | ID: mdl-38874519
ABSTRACT
Augmentation of the nasal dorsum often requires implantation of structural material. Existing methods include autologous, cadaveric or alloplastic materials and injectable hydrogels. Each of these options is associated with considerable limitations. There is an ongoing need for precise and versatile implants that produce long-lasting craniofacial augmentation. Four separate polylactic acid (PLA) dorsal nasal implant designs were 3D-printed. Two implants had internal PLA rebar of differing porosities and two were designed as "shells" of differing porosities. Shell designs were implanted without infill or with either minced or zested processed decellularized ovine cartilage infill to serve as a "biologic rebar", yielding eight total treatment groups. Scaffolds were implanted heterotopically on rat dorsa (N = 4 implants per rat) for explant after 3, 6, and 12 months followed by volumetric, histopathologic, and biomechanical analysis. Low porosity implants with either minced cartilage or PLA rebar infill had superior volume retention across all timepoints. Overall, histopathologic and immunohistochemical analysis showed a resolving inflammatory response with an M1/M2 ratio consistently favoring tissue regeneration over the study course. However, xenograft cartilage showed areas of degradation and pro-inflammatory infiltrate contributing to volume and contour loss over time. Biomechanical analysis revealed all constructs had equilibrium and instantaneous moduli higher than human septal cartilage controls. Biocompatible, degradable polymer implants can induce healthy neotissue ingrowth resulting in guided soft tissue augmentation and offer a simple, customizable and clinically-translatable alternative to existing craniofacial soft tissue augmentation materials. PLA-only implants may be superior to combination PLA and xenograft implants due to contour irregularities associated with cartilage degradation.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article